Correlation Between 775371AU1 and Spyre Therapeutics

Can any of the company-specific risk be diversified away by investing in both 775371AU1 and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 775371AU1 and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ROHM HAAS 785 and Spyre Therapeutics, you can compare the effects of market volatilities on 775371AU1 and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 775371AU1 with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 775371AU1 and Spyre Therapeutics.

Diversification Opportunities for 775371AU1 and Spyre Therapeutics

0.83

Correlation Coefficient

775371AU1  Spyre Therapeutics

Very poor diversification

The 3 months correlation between 775371AU1 and Spyre is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding ROHM HAAS 785 and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and 775371AU1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ROHM HAAS 785 are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of 775371AU1 i.e., 775371AU1 and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between 775371AU1 and Spyre Therapeutics

Assuming the 90 days trading horizon ROHM HAAS 785 is expected to generate 0.14 times more return on investment than Spyre Therapeutics. However, ROHM HAAS 785 is 7.13 times less risky than Spyre Therapeutics. It trades about -0.14 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.19 per unit of risk. If you would invest  11,132  in ROHM HAAS 785 on October 25, 2024 and sell it today you would lose (352.00) from holding ROHM HAAS 785 or give up 3.16% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	66.67%
Values	Daily Returns

ROHM HAAS 785  vs.  Spyre Therapeutics

ROHM HAAS 785

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ROHM HAAS 785 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 775371AU1 is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with 775371AU1 and Spyre Therapeutics

The main advantage of trading using opposite 775371AU1 and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 775371AU1 position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.

The idea behind ROHM HAAS 785 and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.